Reconstructive surgery for sequellae of Mycobacterium ulcerans infection (Buruli ulcer) of the upper limb

References

• WHO Updated February 2017 Media Centre Fact Sheets: Buruli ulcer (Mycobacterium ulcerans infection); [cited 2017 Oct 30]. Available from: http://www.who.int/mediacentre/factsheets/fs199/en/.
   Google Scholar
• Amofah G, Bonsu F, Tetteh C, et al. Buruli ulcer in Ghana: results of a national case search. Emerg Infect Dis. 2002;8(2):167–170.
   PubMed Web of Science ®Google Scholar
• Debacker M, Aguiar J, Steunou C, et al. Mycobacterium ulcerans disease (Buruli ulcer) in rural hospital, Southern Benin, 1997–2001. Emerg Infect Dis. 2004;10(8):1391–1398.
   PubMed Web of Science ®Google Scholar
• MacCallum P, Tolhurst JC, Buckle G, et al. A new mycobacterial infection in man. J Pathol. 1948;60(1):93–122.
   Web of Science ®Google Scholar
• WHO. 2017. Neglected diseases. Buruli ulcer. Number of new cases of Buruli ulcer reported (2002–2016).; [cited 2017 Oct 30]. Available from: http://apps.who.int/neglected_diseases/ntddata/buruli/buruli.html.
   Google Scholar
• WHO. 2012. Treatment of Mycobacterium ulcerans infection (Buruli ulcer). Guidance for workers; [cited 2017 Oct 30]. Available from: http://apps.who.int/iris/bitstream/10665/77771/1/9789241503402_eng.pdf?ua=1.
   Google Scholar
• Yotsu RR, Nakanaga K, Hoshino Y, et al. Buruli ulcer and current situation in Japan: a new emerging cutaneous Mycobacterium infection. J Dermatol. 2012;39(7):587–593.
   PubMed Web of Science ®Google Scholar
• En J, Goto M, Nakanaga K, et al. Mycolactone is responsible for the painlessness of Mycobacterium ulcerans infection (Buruli ulcer) in a murine study. Infect Immun. 2008;76(5):2002–2007.
   PubMed Web of Science ®Google Scholar
• George KM, Chatterjee D, Gunawardana G, et al. Mycolactone: a polyketide toxin from Mycobacterium ulcerans required for virulence. Science. 1999;283(5403):854–857.
   PubMed Web of Science ®Google Scholar
• Nakanaga K, Yotsu RR, Hoshino Y, et al. Buruli ulcer and mycolactone-producing mycobacteria. Jpn J Infect Dis. 2013;66(2):83–88.
   PubMed Web of Science ®Google Scholar
• Adusumilli S, Mve-Obiang A, Soarer T, et al. Mycobacterium ulcerans toxic macrolide, mycolactone modulates the host immune response and cellular location of M. ulcerans in vitro and in vivo. Cell Microbiol. 2005;7(9):1295–1304.
   PubMed Web of Science ®Google Scholar
• Baron L, Paatero AO, Morel JD, et al. Mycolactone subverts immunity by selectively blocking the Sec61 translocon. J Exp Med. 2016;213(13):2885–2896.
   PubMed Web of Science ®Google Scholar
• George KM, Barker LP, Welty DM, et al. Partial purification and characterization of biological effects of a lipid toxin produced by Mycobacterium ulcerans. Infect Immun. 1998;66(2):587–593.
   PubMed Web of Science ®Google Scholar
• Marsollier L, Brodin P, Jackson M, et al. Impact of Mycobacterium ulcerans biofilm on transmissibility to ecological niches and Buruli ulcer pathogenesis. PLoS Pathog. 2007;3(5):e62.
   PubMed Web of Science ®Google Scholar
• Tsukagoshi S, Dehn TC. Buruli ulcer in a nine-month-old boy. Ann R Coll Surg Engl. 2012;94(7):e215-216.
   Web of Science ®Google Scholar
• Ackumey MM, Gyapong M, Pappoe M, Maclean CK, Weiss MG. Socio-cultural determinants of timely and delayed treatment of Buruli ulcer: implications for disease control. Infect Dis Poverty. 2012;1(1):6.
   PubMed Web of Science ®Google Scholar
• Alferink M, van der Werf TS, Sopoh GE, et al. Perceptions on the effectiveness of treatment and the timeline of Buruli ulcer influence pre-hospital delay reported by healthy individuals. PLoS Negl Trop Dis. 2013;7(1):e2014.
   PubMed Web of Science ®Google Scholar
• de Zeeuw J, Omansen TF, Douwstra M, et al. Persisting social participation restrictions among former Buruli ulcer patients in Ghana and Benin. PLoS Negl Trop Dis. 2014;8(11):e3303. Erratum in: PLoS Negl Trop Dis. 2014 Dec;8(12):e3418. Stientstra, Ymkje [corrected to Stienstra, Ymkje]
   PubMed Web of Science ®Google Scholar
• Trubiano JA, Lavender CJ, Fyfe JA, et al. The incubation period of Buruli ulcer (Mycobacterium ulcerans infection). PLoS Negl Trop Dis. 2013;7(10):e2463.
   PubMed Web of Science ®Google Scholar
• Stinear T, Ross BC, Davies JK, et al. Identification and characterization of IS2404 and IS2606: two distinct repeated sequences for detection of Mycobacterium ulcerans by PCR. J Clin Microbiol. 1999;37(4):1018–1023.
   PubMed Web of Science ®Google Scholar
• Yeboah-Manu D, Danso E, Ampah K, et al. Isolation of Mycobacterium ulcerans from swab and fine-needle-aspiration specimens. J Clin Microbiol. 2011;49(5):1997–1999.
   PubMed Web of Science ®Google Scholar
• Converse PJ, Nuermberger EL, Almeida DV, et al. Treating Mycobacterium ulcerans disease (Buruli ulcer): from surgery to antibiotics, is the pill mightier than the knife? Future Microbiol. 2011;6(10):1185–1198.
   PubMed Web of Science ®Google Scholar
• O’Brien DP, Hughes AJ, Cheng AC, et al. Outcomes for Mycobacteriun ulcerans infection with combined surgery and antibiotic therapy: findings from a south-eastern Australia case series. Med J Aust. 2007;186(2):58–61.
   PubMed Web of Science ®Google Scholar
• Johnson PD, Hayman JA, Quek TY, et al. Consensus recommendations for the diagnosis, treatment and control of Mycobacterium ulcerans infection (Bairnsdale or Buruli ulcer) in Victoria, Australia. Med J Aust. 2007;186(2):64–68.
   PubMed Web of Science ®Google Scholar
• O’Brien DP, Ford N, Vitoria M, et al. Management of BU-HIV co-infection. Trop Med Int Health. 2014;19(9):1040–1047.
   PubMed Web of Science ®Google Scholar
• Knipper P, Zilliox R, Johnson C, et al. Ulcère de Buruli et chirurgie plastique au dispensaire. Ann Chir Plast Esth. 2004;49(3):265–272.
   PubMedGoogle Scholar
• Radford AJ. The surgical management of lesions of ulcerans infections due to Mycobacterium ulcerans, revisited. Trans R Soc Trop Med Hyg. 2009;103(10):981–984.
   PubMed Web of Science ®Google Scholar
• Ouattara D, Meningaud JP, Kaba L, et al. [Treatment of Buruli ulcer desease by excision and skin graft]. Ann Chir Plast Esthet. 2004;49(1):11–16.
   PubMedGoogle Scholar
• Adu EJ. Management of contractures: a five-year experience at Komfo Anokye Teaching Hospital in Kumasi. Ghana Med J. 2011;45(2):66–72.
   PubMedGoogle Scholar
• Murase C, Kono M, Nakanaga K, et al. Buruli ulcer successfully treated with negative-pressure wound therapy. JAMA Dermatol. 2015;151(10):1137–1139.
   PubMed Web of Science ®Google Scholar
• Kibadi AK. Relapses after surgical treatment of Buruli ulcer in Africa. Bull Soc Pathol Exot. 2006;99(4):230–235.
   PubMedGoogle Scholar
• Barogui Y, Johnson RC, van der Werf TS, et al. Functional limitations after surgical or antibiotic treatment for Buruli ulcer in Benin. Am J Trop Med Hyg. 2009;81(1):82–87.
   PubMed Web of Science ®Google Scholar
• O'Brien DP, Walton A, Hughes AJ, et al. Risk factors for recurrent Mycobacterium ulcerans disease after exclusive surgical treatment in an Australian cohort. Med J Aust. 2013;198(8):436–439.
   PubMed Web of Science ®Google Scholar
• Adu E, Ampadu E, Acheampong D. Surgical management of Buruli ulcer disease: a four-year experience from four endemic districts in Ghana. Ghana Med J. 2011;45(1):4–9.
   PubMedGoogle Scholar
• Velding K, Klis SA, Abass KM, et al. Wound care in Buruli ulcer disease in Ghana and Benin. Am J Trop Med Hyg. 2014;91(2):313–318.
   PubMed Web of Science ®Google Scholar
• Guifo ML, Essiene A, Ngo Nsoga M, et al. Surgical management of chronic wounds in a Buruli ulcer endemic area in Central Africa. World J Surg. 2016;40(5):1041–1046.
   PubMed Web of Science ®Google Scholar